|
Mon, 07/01/2019 - 15:27 |
Intermountain Healthcare Saves Millions of Dollars Teaming with Surgeons to Negotiate Lower Prices on Supplies |
Intermountain H... |
|
Thu, 02/21/2019 - 06:06 |
TRHC Announces Launch and Location of New Scientific Precision Pharmacotherapy Research & Development Institute |
Tabula Rasa Hea... |
|
Wed, 12/19/2018 - 05:26 |
The Ralph C. Wilson, Jr. Foundation Awards Grant to Support Hamtramck's Veterans Memorial Park Master Plan |
Michigan Munici... |
|
Mon, 12/17/2018 - 07:46 |
Grant to Support Master Plan for Veterans Park Campus, Hamtramck Stadium |
Michigan Munici... |
|
Fri, 12/07/2018 - 17:49 |
Mount Sinai Researchers: 20-Year Study Reveals Pseudopolyps Do Not Predict Neoplasia in IBD patients |
Mount Sinai |
|
Thu, 11/15/2018 - 17:27 |
Atrium Health Agrees to Settle Antitrust Lawsuit and Eliminate Anticompetitive Steering Restrictions |
DOJ |
|
Tue, 10/30/2018 - 22:50 |
Asterias Biotherapeutics Announces Positive Outcome from Data Review from OPC1 Spinal Cord Injury Study |
Asterias Biothe... |
|
Mon, 10/08/2018 - 09:48 |
Leveraging Information Technology to Improve Vaccination Rates in Americas Communities #NHITWeek |
HIMSS |
|
Wed, 09/26/2018 - 09:52 |
National Business Group on Health Honors Blue Cross and Blue Shield of Alabama with Best Employers for Healthy Lifestyles Award |
Blue Cross Blue... |
|
Wed, 09/19/2018 - 23:40 |
FDA Accepts Asterias Biotherapeutics Request to Meet and Discuss Next Phase of Development for OPC1 Spinal Cord Injury Clinical Program |
Asterias Biothe... |
|
Tue, 09/11/2018 - 22:58 |
Asterias Provides 24 Month Cohort 2 Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury |
Asterias Biothe... |
|
Thu, 08/23/2018 - 07:06 |
Innovations to Omnicell Patient Engagement Platform Support Value-Based, Patient-Centered Care |
Omnicell |
|
Mon, 07/30/2018 - 22:24 |
Asterias Provides 12 Month Cohort 3 and 4 Update for its AST-OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury |
Asterias Biothe... |
|
Mon, 07/16/2018 - 21:57 |
Asterias Provides Six Month Data Readout for its AST-OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury |
Asterias Biothe... |
|
Tue, 06/26/2018 - 20:17 |
Significant Reductions in Costly Pulmonary Complications with Use of Drug-Free Device |
staronepr |
|
Mon, 06/18/2018 - 13:40 |
Myriad's BRACAnalysis CDx Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Talazoparib in Metastatic Breast Cancer |
Myriad |
|
Wed, 06/06/2018 - 03:52 |
Crescendo Bioscience Announces Four Studies with Vectra DA Will Be Featured at the 2018 European League Against Rheumatism Annual Meeting |
Myriad |
|
Fri, 06/01/2018 - 10:44 |
Myriad Genetics Presents Second Pivotal Validation Study for riskScore Test at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting |
Myriad |
|
Thu, 05/31/2018 - 13:13 |
Myriad Genetics to Present at Two Upcoming Investor Conferences |
Myriad |
|
Thu, 05/31/2018 - 13:06 |
GeneSight Guided Treatment Significantly Improves Outcomes for Patients with Major Depression Treated in the Primary Care Setting |
Myriad |
|
Thu, 05/31/2018 - 09:15 |
New training centre for rising biomedical innovators in Sydney |
SydneyUniv |
|
Mon, 05/28/2018 - 16:04 |
Myriad Genetics Signs Definitive Agreement to Acquire Counsyl, Inc. |
Myriad |
|
Wed, 05/23/2018 - 15:04 |
Myriad Announces Seven New Payer Coverage Decisions for Prolaris |
Myriad |
|
Tue, 05/15/2018 - 05:25 |
Myriad Genetics to Present Eight Studies at the 2018 American Society of Clinical Oncology Annual Meeting |
Myriad |
|
Tue, 05/08/2018 - 11:51 |
AACC Honors Representative Kevin Yoder for His Commitment to Improving Patient Care Through Uniform Clinical Test Results |
AACC.org |
